ICAM1 and Parkinson disease: Using a different multiplexed immunoassay by Myriad RBM, Austin, TX, USA (http://rbm.myriad.com) with an assessment of 41 inflammatory markers in CSF/serum pairs in 453 sporadic PD patients, we could previously show that the most important inflammatory mediators associated with motor and cognitive function and with neurodegenerative/PD-specific biomarkers were FABP, ICAM-1, IL-8, MCP-1, MIP-1-beta and SCF.